Snady H, Lieber C S
Section of Liver Disease and Nutrition, Veterans Administration Medical Center, Bronx, New York.
Am J Gastroenterol. 1988 Mar;83(3):249-55.
To assess side effects of propranolol in the treatment of portal hypertension, we measured blood ammonia in 14 cirrhotics before and after administration of propranolol, and in six cirrhotics before and after placebo. We evaluated ammonia blood levels obtained from three sites: venous, arterial, and arterialized-venous, obtained by warming the forearm. Ammonia concentration of arterial and arterialized-venous blood were abnormal for all cirrhotics studied and significantly greater than the ammonia concentration of venous blood (p less than 0.01). When propranolol was administered to patients with alcoholic cirrhosis and marginal liver function, as reflected by ammonia levels above 60 microM, it caused a significant increase in ammonia levels in arterialized-venous and arterial, but not in venous, blood (p less than 0.05). Propranolol caused a significant increase in the time required to perform sensitive psychometric tests (p less than 0.05). Encephalopathy usually became clinically apparent when the mean of the arterial and arterialized-venous blood ammonia levels rose above 122 microM.
为评估普萘洛尔治疗门静脉高压症的副作用,我们测定了14例肝硬化患者服用普萘洛尔前后以及6例肝硬化患者服用安慰剂前后的血氨水平。我们评估了从三个部位获取的血氨水平:静脉血、动脉血以及通过加热前臂获得的动脉化静脉血。所有研究的肝硬化患者的动脉血和动脉化静脉血氨浓度均异常,且显著高于静脉血氨浓度(p<0.01)。当给酒精性肝硬化且肝功能处于边缘状态(以血氨水平高于60微摩尔/升为指标)的患者服用普萘洛尔时,动脉化静脉血和动脉血中的氨水平显著升高,但静脉血中的氨水平未升高(p<0.05)。普萘洛尔导致进行敏感心理测量测试所需时间显著增加(p<0.05)。当动脉血和动脉化静脉血氨水平的平均值升至高于122微摩尔/升时,脑病通常会在临床上显现出来。